Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Toledo Children's Hospital
mi
from 98109
Toledo, OH
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Toledo Children's Hospital
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Lehigh Valley Hospital - Muhlenberg
2341
mi
from 98109
Bethlehem, PA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
2341
mi
from 98109
Bethlehem, PA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
2273
mi
from 98109
Danville, PA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
2273
mi
from 98109
Danville, PA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Palmetto Health Richland
2319
mi
from 98109
Columbia, SC
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Palmetto Health Richland
2319
mi
from 98109
Columbia, SC
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Sanford USD Medical Center - Sioux Falls
1263
mi
from 98109
Sioux Falls, SD
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
1263
mi
from 98109
Sioux Falls, SD
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Driscoll Children's Hospital
1919
mi
from 98109
Corpus Christi, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Driscoll Children's Hospital
1919
mi
from 98109
Corpus Christi, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
1786
mi
from 98109
Fort Sam Houston, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
1786
mi
from 98109
Fort Sam Houston, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Cook Children's Medical Center
1660
mi
from 98109
Fort Worth, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
1780
mi
from 98109
San Antonio, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Methodist Children's Hospital of South Texas
1780
mi
from 98109
San Antonio, TX
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Methodist Children's Hospital of South Texas
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of The King's Daughters
2429
mi
from 98109
Norfolk, VA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of The King's Daughters
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
229
mi
from 98109
Spokane, WA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Providence Sacred Heart Medical Center & Children's Hospital
229
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Madigan Army Medical Center
27
mi
from 98109
Tacoma, WA
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Madigan Army Medical Center
27
mi
from 98109
Tacoma, WA
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Marshfield Clinic
1542
mi
from 98109
Marshfield, WI
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
CancerCare Manitoba
1152
mi
from 98109
Winnipeg,
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
CancerCare Manitoba
1152
mi
from 98109
Winnipeg,
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
2322
mi
from 98109
Washington,
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University
2320
mi
from 98109
Washington,
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Lombardi Comprehensive Cancer Center at Georgetown University
2320
mi
from 98109
Washington,
Click here to add this to my saved trials
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
2402
mi
from 98109
Bronx, NY
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
Livestock Contact and MRSA in Rural Areas
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Status: Enrolling
Updated:  12/31/1969
University of Iowa
1557
mi
from 98109
Coralville, IA
Livestock Contact and MRSA in Rural Areas
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Status: Enrolling
Updated: 12/31/1969
University of Iowa
1557
mi
from 98109
Coralville, IA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Stanford University
705
mi
from 98109
Stanford, CA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Stanford University
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Denver
1026
mi
from 98109
Aurora, CO
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Columbia University
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Duke University
2341
mi
from 98109
Durham, NC
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Duke University
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve-Metrohealth
2021
mi
from 98109
Cleveland, OH
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve-Metrohealth
2021
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Brown University
2486
mi
from 98109
Providence, RI
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Brown University
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Univ of Texas Galveston
1937
mi
from 98109
Galveston, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Univ of Texas Galveston
1937
mi
from 98109
Galveston, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
University of Utah Medical Center
702
mi
from 98109
Salt Lake City, UT
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
University of Utah Medical Center
702
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated:  12/31/1969
Magee-Womens Hospital of UPMC
2134
mi
from 98109
Pittsburgh, PA
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Status: Enrolling
Updated: 12/31/1969
Magee-Womens Hospital of UPMC
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
680
mi
from 98109
San Francisco, CA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2322
mi
from 98109
Washington,
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2729
mi
from 98109
Coral Gables, FL
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2729
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2549
mi
from 98109
Orlando, FL
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2549
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2176
mi
from 98109
Atlanta, GA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2176
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2400
mi
from 98109
New York, NY
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2338
mi
from 98109
Durham, NC
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2371
mi
from 98109
Philadelphia, PA
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2371
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1769
mi
from 98109
Austin, TX
HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1769
mi
from 98109
Austin, TX
Click here to add this to my saved trials